nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—CACNA1A—cerebellar cortex—malignant glioma	0.122	0.356	CbGeAlD
Pregabalin—CACNA1A—brainstem—malignant glioma	0.0192	0.056	CbGeAlD
Pregabalin—SLC1A1—brainstem—malignant glioma	0.0188	0.0547	CbGeAlD
Pregabalin—CACNA1A—telencephalon—malignant glioma	0.0171	0.0497	CbGeAlD
Pregabalin—SLC1A1—telencephalon—malignant glioma	0.0167	0.0485	CbGeAlD
Pregabalin—CACNA1A—medulla oblongata—malignant glioma	0.0134	0.039	CbGeAlD
Pregabalin—CACNA2D2—telencephalon—malignant glioma	0.012	0.035	CbGeAlD
Pregabalin—SLC1A1—spinal cord—malignant glioma	0.0117	0.034	CbGeAlD
Pregabalin—CACNA2D1—brainstem—malignant glioma	0.00974	0.0283	CbGeAlD
Pregabalin—CACNA1A—central nervous system—malignant glioma	0.0097	0.0282	CbGeAlD
Pregabalin—CACNA1A—cerebellum—malignant glioma	0.00948	0.0276	CbGeAlD
Pregabalin—SLC1A1—central nervous system—malignant glioma	0.00947	0.0276	CbGeAlD
Pregabalin—SLC1A1—cerebellum—malignant glioma	0.00925	0.0269	CbGeAlD
Pregabalin—CACNA2D2—midbrain—malignant glioma	0.00863	0.0251	CbGeAlD
Pregabalin—CACNA2D2—spinal cord—malignant glioma	0.00842	0.0245	CbGeAlD
Pregabalin—CACNA1A—brain—malignant glioma	0.0077	0.0224	CbGeAlD
Pregabalin—SLC1A1—brain—malignant glioma	0.00752	0.0219	CbGeAlD
Pregabalin—CACNA2D2—central nervous system—malignant glioma	0.00683	0.0199	CbGeAlD
Pregabalin—CACNA2D2—cerebellum—malignant glioma	0.00667	0.0194	CbGeAlD
Pregabalin—CACNA2D2—brain—malignant glioma	0.00542	0.0158	CbGeAlD
Pregabalin—CACNA1A—Synaptic Vesicle Pathway—SYP—malignant glioma	0.00509	0.133	CbGpPWpGaD
Pregabalin—CACNA2D1—central nervous system—malignant glioma	0.00491	0.0143	CbGeAlD
Pregabalin—CACNA2D1—cerebellum—malignant glioma	0.0048	0.014	CbGeAlD
Pregabalin—CACNA2D1—brain—malignant glioma	0.0039	0.0114	CbGeAlD
Pregabalin—Memory impairment—Temozolomide—malignant glioma	0.00305	0.00493	CcSEcCtD
Pregabalin—Hyperaesthesia—Temozolomide—malignant glioma	0.00305	0.00493	CcSEcCtD
Pregabalin—Injection site pain—Carmustine—malignant glioma	0.00303	0.0049	CcSEcCtD
Pregabalin—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00291	0.0047	CcSEcCtD
Pregabalin—Petechiae—Temozolomide—malignant glioma	0.00291	0.0047	CcSEcCtD
Pregabalin—Speech disorder—Carmustine—malignant glioma	0.00288	0.00466	CcSEcCtD
Pregabalin—Accidental injury—Carmustine—malignant glioma	0.0028	0.00453	CcSEcCtD
Pregabalin—Speech disorder—Temozolomide—malignant glioma	0.00278	0.0045	CcSEcCtD
Pregabalin—Disturbance in attention—Temozolomide—malignant glioma	0.00276	0.00447	CcSEcCtD
Pregabalin—Breast pain—Temozolomide—malignant glioma	0.00274	0.00443	CcSEcCtD
Pregabalin—Amenorrhoea—Temozolomide—malignant glioma	0.00272	0.0044	CcSEcCtD
Pregabalin—Thinking abnormal—Carmustine—malignant glioma	0.0027	0.00437	CcSEcCtD
Pregabalin—Viral infection—Temozolomide—malignant glioma	0.00265	0.00428	CcSEcCtD
Pregabalin—Leukocytosis—Carmustine—malignant glioma	0.00263	0.00426	CcSEcCtD
Pregabalin—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00263	0.00426	CcSEcCtD
Pregabalin—Herpes simplex—Temozolomide—malignant glioma	0.0026	0.0042	CcSEcCtD
Pregabalin—Gait disturbance—Carmustine—malignant glioma	0.00254	0.0041	CcSEcCtD
Pregabalin—Coordination abnormal—Carmustine—malignant glioma	0.00252	0.00408	CcSEcCtD
Pregabalin—Neck pain—Carmustine—malignant glioma	0.00251	0.00405	CcSEcCtD
Pregabalin—Pulmonary embolism—Carmustine—malignant glioma	0.00248	0.004	CcSEcCtD
Pregabalin—Injection site reaction—Carmustine—malignant glioma	0.00246	0.00398	CcSEcCtD
Pregabalin—Gait disturbance—Temozolomide—malignant glioma	0.00245	0.00396	CcSEcCtD
Pregabalin—Respiratory failure—Temozolomide—malignant glioma	0.00244	0.00394	CcSEcCtD
Pregabalin—Coordination abnormal—Temozolomide—malignant glioma	0.00244	0.00394	CcSEcCtD
Pregabalin—Pulmonary embolism—Temozolomide—malignant glioma	0.00239	0.00387	CcSEcCtD
Pregabalin—Vaginal inflammation—Temozolomide—malignant glioma	0.00239	0.00387	CcSEcCtD
Pregabalin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00239	0.00387	CcSEcCtD
Pregabalin—Depressed level of consciousness—Carmustine—malignant glioma	0.00239	0.00387	CcSEcCtD
Pregabalin—Urinary incontinence—Carmustine—malignant glioma	0.00239	0.00387	CcSEcCtD
Pregabalin—SLC1A1—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.00237	0.0618	CbGpPWpGaD
Pregabalin—Skin exfoliation—Carmustine—malignant glioma	0.00236	0.00382	CcSEcCtD
Pregabalin—Candida infection—Carmustine—malignant glioma	0.00236	0.00382	CcSEcCtD
Pregabalin—Neuropathy—Carmustine—malignant glioma	0.00232	0.00376	CcSEcCtD
Pregabalin—Urinary incontinence—Temozolomide—malignant glioma	0.00231	0.00374	CcSEcCtD
Pregabalin—Depressed level of consciousness—Temozolomide—malignant glioma	0.00231	0.00374	CcSEcCtD
Pregabalin—Candida infection—Temozolomide—malignant glioma	0.00228	0.00369	CcSEcCtD
Pregabalin—Skin exfoliation—Temozolomide—malignant glioma	0.00228	0.00369	CcSEcCtD
Pregabalin—Coma—Carmustine—malignant glioma	0.00226	0.00366	CcSEcCtD
Pregabalin—Vaginal infection—Temozolomide—malignant glioma	0.00226	0.00365	CcSEcCtD
Pregabalin—Neuropathy—Temozolomide—malignant glioma	0.00225	0.00363	CcSEcCtD
Pregabalin—Neoplasm—Carmustine—malignant glioma	0.00224	0.00362	CcSEcCtD
Pregabalin—Gynaecomastia—Carmustine—malignant glioma	0.00221	0.00358	CcSEcCtD
Pregabalin—Dry eye—Temozolomide—malignant glioma	0.00221	0.00357	CcSEcCtD
Pregabalin—Neoplasm—Temozolomide—malignant glioma	0.00216	0.0035	CcSEcCtD
Pregabalin—Abnormal vision—Carmustine—malignant glioma	0.00216	0.00349	CcSEcCtD
Pregabalin—Sepsis—Carmustine—malignant glioma	0.00215	0.00347	CcSEcCtD
Pregabalin—Mental disability—Carmustine—malignant glioma	0.00215	0.00347	CcSEcCtD
Pregabalin—Abnormal vision—Temozolomide—malignant glioma	0.00209	0.00337	CcSEcCtD
Pregabalin—Phlebitis—Carmustine—malignant glioma	0.00209	0.00337	CcSEcCtD
Pregabalin—Mental disability—Temozolomide—malignant glioma	0.00208	0.00336	CcSEcCtD
Pregabalin—Thrombophlebitis—Carmustine—malignant glioma	0.00208	0.00336	CcSEcCtD
Pregabalin—Diabetes mellitus—Carmustine—malignant glioma	0.00207	0.00334	CcSEcCtD
Pregabalin—Ear pain—Temozolomide—malignant glioma	0.00204	0.00329	CcSEcCtD
Pregabalin—Thrombophlebitis—Temozolomide—malignant glioma	0.00201	0.00324	CcSEcCtD
Pregabalin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.002	0.00323	CcSEcCtD
Pregabalin—Eye pain—Carmustine—malignant glioma	0.00199	0.00322	CcSEcCtD
Pregabalin—Gastroenteritis—Temozolomide—malignant glioma	0.00196	0.00317	CcSEcCtD
Pregabalin—Injury—Carmustine—malignant glioma	0.00195	0.00316	CcSEcCtD
Pregabalin—Vascular purpura—Temozolomide—malignant glioma	0.00194	0.00314	CcSEcCtD
Pregabalin—Deafness—Temozolomide—malignant glioma	0.00194	0.00314	CcSEcCtD
Pregabalin—Eye pain—Temozolomide—malignant glioma	0.00192	0.00311	CcSEcCtD
Pregabalin—Amnesia—Carmustine—malignant glioma	0.00191	0.00309	CcSEcCtD
Pregabalin—Nasal congestion—Temozolomide—malignant glioma	0.00191	0.00308	CcSEcCtD
Pregabalin—Hot flush—Temozolomide—malignant glioma	0.00186	0.003	CcSEcCtD
Pregabalin—Amnesia—Temozolomide—malignant glioma	0.00185	0.00299	CcSEcCtD
Pregabalin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00184	0.00298	CcSEcCtD
Pregabalin—Menopausal symptoms—Temozolomide—malignant glioma	0.00184	0.00298	CcSEcCtD
Pregabalin—Thirst—Temozolomide—malignant glioma	0.00182	0.00295	CcSEcCtD
Pregabalin—Hyponatraemia—Carmustine—malignant glioma	0.0018	0.00292	CcSEcCtD
Pregabalin—Purpura—Temozolomide—malignant glioma	0.0018	0.00291	CcSEcCtD
Pregabalin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.0018	0.00291	CcSEcCtD
Pregabalin—Diplopia—Carmustine—malignant glioma	0.0018	0.00291	CcSEcCtD
Pregabalin—Diplopia—Temozolomide—malignant glioma	0.00174	0.00281	CcSEcCtD
Pregabalin—Face oedema—Carmustine—malignant glioma	0.00173	0.00281	CcSEcCtD
Pregabalin—Affect lability—Temozolomide—malignant glioma	0.00171	0.00276	CcSEcCtD
Pregabalin—Ataxia—Carmustine—malignant glioma	0.00169	0.00273	CcSEcCtD
Pregabalin—Face oedema—Temozolomide—malignant glioma	0.00168	0.00271	CcSEcCtD
Pregabalin—Liver function test abnormal—Carmustine—malignant glioma	0.00166	0.00268	CcSEcCtD
Pregabalin—Mood swings—Temozolomide—malignant glioma	0.00164	0.00266	CcSEcCtD
Pregabalin—Hypokalaemia—Carmustine—malignant glioma	0.00164	0.00265	CcSEcCtD
Pregabalin—Ataxia—Temozolomide—malignant glioma	0.00163	0.00264	CcSEcCtD
Pregabalin—Dehydration—Temozolomide—malignant glioma	0.00161	0.00261	CcSEcCtD
Pregabalin—Dry skin—Temozolomide—malignant glioma	0.00159	0.00257	CcSEcCtD
Pregabalin—Muscular weakness—Carmustine—malignant glioma	0.00158	0.00256	CcSEcCtD
Pregabalin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—malignant glioma	0.00158	0.0412	CbGpPWpGaD
Pregabalin—Hypokalaemia—Temozolomide—malignant glioma	0.00158	0.00256	CcSEcCtD
Pregabalin—Breast disorder—Temozolomide—malignant glioma	0.00157	0.00254	CcSEcCtD
Pregabalin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00156	0.00253	CcSEcCtD
Pregabalin—Dysphagia—Carmustine—malignant glioma	0.00155	0.00251	CcSEcCtD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—ATP1B2—malignant glioma	0.00154	0.0401	CbGpPWpGaD
Pregabalin—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00153	0.00248	CcSEcCtD
Pregabalin—Muscular weakness—Temozolomide—malignant glioma	0.00153	0.00248	CcSEcCtD
Pregabalin—Abdominal distension—Temozolomide—malignant glioma	0.00151	0.00244	CcSEcCtD
Pregabalin—Dysphagia—Temozolomide—malignant glioma	0.0015	0.00243	CcSEcCtD
Pregabalin—Pancytopenia—Carmustine—malignant glioma	0.00147	0.00239	CcSEcCtD
Pregabalin—Neutropenia—Carmustine—malignant glioma	0.00145	0.00235	CcSEcCtD
Pregabalin—Bronchitis—Temozolomide—malignant glioma	0.00144	0.00233	CcSEcCtD
Pregabalin—Pancytopenia—Temozolomide—malignant glioma	0.00143	0.00231	CcSEcCtD
Pregabalin—Dysuria—Temozolomide—malignant glioma	0.0014	0.00227	CcSEcCtD
Pregabalin—Neutropenia—Temozolomide—malignant glioma	0.0014	0.00227	CcSEcCtD
Pregabalin—Hyperglycaemia—Carmustine—malignant glioma	0.0014	0.00227	CcSEcCtD
Pregabalin—SLC1A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.0014	0.0364	CbGpPWpGaD
Pregabalin—Pneumonia—Carmustine—malignant glioma	0.00139	0.00225	CcSEcCtD
Pregabalin—Pollakiuria—Temozolomide—malignant glioma	0.00139	0.00224	CcSEcCtD
Pregabalin—Erectile dysfunction—Temozolomide—malignant glioma	0.00138	0.00224	CcSEcCtD
Pregabalin—Depression—Carmustine—malignant glioma	0.00138	0.00223	CcSEcCtD
Pregabalin—Photosensitivity reaction—Temozolomide—malignant glioma	0.00137	0.00222	CcSEcCtD
Pregabalin—Weight increased—Temozolomide—malignant glioma	0.00137	0.00221	CcSEcCtD
Pregabalin—Renal failure—Carmustine—malignant glioma	0.00136	0.0022	CcSEcCtD
Pregabalin—Weight decreased—Temozolomide—malignant glioma	0.00136	0.0022	CcSEcCtD
Pregabalin—Neuropathy peripheral—Carmustine—malignant glioma	0.00136	0.0022	CcSEcCtD
Pregabalin—Hyperglycaemia—Temozolomide—malignant glioma	0.00135	0.00219	CcSEcCtD
Pregabalin—Stomatitis—Carmustine—malignant glioma	0.00135	0.00218	CcSEcCtD
Pregabalin—Urinary tract infection—Carmustine—malignant glioma	0.00135	0.00218	CcSEcCtD
Pregabalin—Pneumonia—Temozolomide—malignant glioma	0.00135	0.00218	CcSEcCtD
Pregabalin—Infestation NOS—Temozolomide—malignant glioma	0.00134	0.00216	CcSEcCtD
Pregabalin—Infestation—Temozolomide—malignant glioma	0.00134	0.00216	CcSEcCtD
Pregabalin—Depression—Temozolomide—malignant glioma	0.00133	0.00216	CcSEcCtD
Pregabalin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00133	0.00215	CcSEcCtD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00133	0.0346	CbGpPWpGaD
Pregabalin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00131	0.00212	CcSEcCtD
Pregabalin—Stomatitis—Temozolomide—malignant glioma	0.0013	0.00211	CcSEcCtD
Pregabalin—Urinary tract infection—Temozolomide—malignant glioma	0.0013	0.0021	CcSEcCtD
Pregabalin—Sinusitis—Temozolomide—malignant glioma	0.00126	0.00203	CcSEcCtD
Pregabalin—Haemoglobin—Carmustine—malignant glioma	0.00125	0.00202	CcSEcCtD
Pregabalin—Haemorrhage—Carmustine—malignant glioma	0.00124	0.00201	CcSEcCtD
Pregabalin—Hypoaesthesia—Carmustine—malignant glioma	0.00124	0.002	CcSEcCtD
Pregabalin—Hallucination—Carmustine—malignant glioma	0.00124	0.002	CcSEcCtD
Pregabalin—Oedema peripheral—Carmustine—malignant glioma	0.00122	0.00198	CcSEcCtD
Pregabalin—Connective tissue disorder—Carmustine—malignant glioma	0.00122	0.00198	CcSEcCtD
Pregabalin—Haemoglobin—Temozolomide—malignant glioma	0.00121	0.00195	CcSEcCtD
Pregabalin—Hepatitis—Temozolomide—malignant glioma	0.0012	0.00194	CcSEcCtD
Pregabalin—Haemorrhage—Temozolomide—malignant glioma	0.0012	0.00194	CcSEcCtD
Pregabalin—Visual impairment—Carmustine—malignant glioma	0.0012	0.00194	CcSEcCtD
Pregabalin—Hallucination—Temozolomide—malignant glioma	0.0012	0.00193	CcSEcCtD
Pregabalin—Hypoaesthesia—Temozolomide—malignant glioma	0.0012	0.00193	CcSEcCtD
Pregabalin—Pharyngitis—Temozolomide—malignant glioma	0.00119	0.00193	CcSEcCtD
Pregabalin—Urinary tract disorder—Temozolomide—malignant glioma	0.00119	0.00192	CcSEcCtD
Pregabalin—Oedema peripheral—Temozolomide—malignant glioma	0.00118	0.00191	CcSEcCtD
Pregabalin—Connective tissue disorder—Temozolomide—malignant glioma	0.00118	0.00191	CcSEcCtD
Pregabalin—Urethral disorder—Temozolomide—malignant glioma	0.00118	0.0019	CcSEcCtD
Pregabalin—Eye disorder—Carmustine—malignant glioma	0.00116	0.00188	CcSEcCtD
Pregabalin—Visual impairment—Temozolomide—malignant glioma	0.00116	0.00187	CcSEcCtD
Pregabalin—Flushing—Carmustine—malignant glioma	0.00115	0.00187	CcSEcCtD
Pregabalin—Erythema multiforme—Temozolomide—malignant glioma	0.00114	0.00184	CcSEcCtD
Pregabalin—Eye disorder—Temozolomide—malignant glioma	0.00112	0.00182	CcSEcCtD
Pregabalin—Tinnitus—Temozolomide—malignant glioma	0.00112	0.00181	CcSEcCtD
Pregabalin—Flushing—Temozolomide—malignant glioma	0.00111	0.0018	CcSEcCtD
Pregabalin—Cardiac disorder—Temozolomide—malignant glioma	0.00111	0.0018	CcSEcCtD
Pregabalin—Arrhythmia—Carmustine—malignant glioma	0.00111	0.0018	CcSEcCtD
Pregabalin—Alopecia—Carmustine—malignant glioma	0.0011	0.00178	CcSEcCtD
Pregabalin—Angiopathy—Temozolomide—malignant glioma	0.00109	0.00176	CcSEcCtD
Pregabalin—Mental disorder—Carmustine—malignant glioma	0.00109	0.00176	CcSEcCtD
Pregabalin—Immune system disorder—Temozolomide—malignant glioma	0.00109	0.00176	CcSEcCtD
Pregabalin—Mediastinal disorder—Temozolomide—malignant glioma	0.00108	0.00175	CcSEcCtD
Pregabalin—Malnutrition—Carmustine—malignant glioma	0.00108	0.00175	CcSEcCtD
Pregabalin—Chills—Temozolomide—malignant glioma	0.00108	0.00174	CcSEcCtD
Pregabalin—Alopecia—Temozolomide—malignant glioma	0.00106	0.00172	CcSEcCtD
Pregabalin—Mental disorder—Temozolomide—malignant glioma	0.00105	0.0017	CcSEcCtD
Pregabalin—Back pain—Carmustine—malignant glioma	0.00105	0.00169	CcSEcCtD
Pregabalin—Malnutrition—Temozolomide—malignant glioma	0.00105	0.00169	CcSEcCtD
Pregabalin—Dysgeusia—Temozolomide—malignant glioma	0.00102	0.00166	CcSEcCtD
Pregabalin—Vision blurred—Carmustine—malignant glioma	0.00102	0.00165	CcSEcCtD
Pregabalin—Tremor—Carmustine—malignant glioma	0.00101	0.00164	CcSEcCtD
Pregabalin—Back pain—Temozolomide—malignant glioma	0.00101	0.00164	CcSEcCtD
Pregabalin—Anaemia—Carmustine—malignant glioma	0.001	0.00162	CcSEcCtD
Pregabalin—Agitation—Carmustine—malignant glioma	0.000994	0.00161	CcSEcCtD
Pregabalin—Vision blurred—Temozolomide—malignant glioma	0.000986	0.00159	CcSEcCtD
Pregabalin—Tremor—Temozolomide—malignant glioma	0.00098	0.00158	CcSEcCtD
Pregabalin—Ill-defined disorder—Temozolomide—malignant glioma	0.00097	0.00157	CcSEcCtD
Pregabalin—Leukopenia—Carmustine—malignant glioma	0.000969	0.00157	CcSEcCtD
Pregabalin—Anaemia—Temozolomide—malignant glioma	0.000967	0.00156	CcSEcCtD
Pregabalin—Agitation—Temozolomide—malignant glioma	0.000961	0.00155	CcSEcCtD
Pregabalin—Angioedema—Temozolomide—malignant glioma	0.000956	0.00155	CcSEcCtD
Pregabalin—Malaise—Temozolomide—malignant glioma	0.000943	0.00153	CcSEcCtD
Pregabalin—Vertigo—Temozolomide—malignant glioma	0.00094	0.00152	CcSEcCtD
Pregabalin—Convulsion—Carmustine—malignant glioma	0.000938	0.00152	CcSEcCtD
Pregabalin—Leukopenia—Temozolomide—malignant glioma	0.000936	0.00151	CcSEcCtD
Pregabalin—Hypertension—Carmustine—malignant glioma	0.000934	0.00151	CcSEcCtD
Pregabalin—Palpitations—Temozolomide—malignant glioma	0.000924	0.00149	CcSEcCtD
Pregabalin—Myalgia—Carmustine—malignant glioma	0.000921	0.00149	CcSEcCtD
Pregabalin—Chest pain—Carmustine—malignant glioma	0.000921	0.00149	CcSEcCtD
Pregabalin—Anxiety—Carmustine—malignant glioma	0.000918	0.00148	CcSEcCtD
Pregabalin—CACNA1A—Type II diabetes mellitus—TNF—malignant glioma	0.000916	0.0239	CbGpPWpGaD
Pregabalin—Cough—Temozolomide—malignant glioma	0.000913	0.00148	CcSEcCtD
Pregabalin—Convulsion—Temozolomide—malignant glioma	0.000906	0.00147	CcSEcCtD
Pregabalin—Hypertension—Temozolomide—malignant glioma	0.000903	0.00146	CcSEcCtD
Pregabalin—Confusional state—Carmustine—malignant glioma	0.00089	0.00144	CcSEcCtD
Pregabalin—Arthralgia—Temozolomide—malignant glioma	0.00089	0.00144	CcSEcCtD
Pregabalin—Myalgia—Temozolomide—malignant glioma	0.00089	0.00144	CcSEcCtD
Pregabalin—Anxiety—Temozolomide—malignant glioma	0.000887	0.00144	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000884	0.00143	CcSEcCtD
Pregabalin—Oedema—Carmustine—malignant glioma	0.000883	0.00143	CcSEcCtD
Pregabalin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—malignant glioma	0.000881	0.023	CbGpPWpGaD
Pregabalin—Discomfort—Temozolomide—malignant glioma	0.00088	0.00142	CcSEcCtD
Pregabalin—Infection—Carmustine—malignant glioma	0.000877	0.00142	CcSEcCtD
Pregabalin—Dry mouth—Temozolomide—malignant glioma	0.000871	0.00141	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000867	0.0226	CbGpPWpGaD
Pregabalin—Thrombocytopenia—Carmustine—malignant glioma	0.000865	0.0014	CcSEcCtD
Pregabalin—Tachycardia—Carmustine—malignant glioma	0.000862	0.00139	CcSEcCtD
Pregabalin—Confusional state—Temozolomide—malignant glioma	0.000861	0.00139	CcSEcCtD
Pregabalin—Oedema—Temozolomide—malignant glioma	0.000853	0.00138	CcSEcCtD
Pregabalin—Anaphylactic shock—Temozolomide—malignant glioma	0.000853	0.00138	CcSEcCtD
Pregabalin—Infection—Temozolomide—malignant glioma	0.000848	0.00137	CcSEcCtD
Pregabalin—Anorexia—Carmustine—malignant glioma	0.000842	0.00136	CcSEcCtD
Pregabalin—Nervous system disorder—Temozolomide—malignant glioma	0.000837	0.00135	CcSEcCtD
Pregabalin—Thrombocytopenia—Temozolomide—malignant glioma	0.000836	0.00135	CcSEcCtD
Pregabalin—Skin disorder—Temozolomide—malignant glioma	0.000829	0.00134	CcSEcCtD
Pregabalin—Hypotension—Carmustine—malignant glioma	0.000825	0.00133	CcSEcCtD
Pregabalin—Hyperhidrosis—Temozolomide—malignant glioma	0.000825	0.00133	CcSEcCtD
Pregabalin—Anorexia—Temozolomide—malignant glioma	0.000814	0.00132	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000805	0.0013	CcSEcCtD
Pregabalin—Insomnia—Carmustine—malignant glioma	0.000799	0.00129	CcSEcCtD
Pregabalin—Paraesthesia—Carmustine—malignant glioma	0.000793	0.00128	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000793	0.0207	CbGpPWpGaD
Pregabalin—Dyspnoea—Carmustine—malignant glioma	0.000787	0.00127	CcSEcCtD
Pregabalin—Somnolence—Carmustine—malignant glioma	0.000785	0.00127	CcSEcCtD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000779	0.0203	CbGpPWpGaD
Pregabalin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000778	0.00126	CcSEcCtD
Pregabalin—Insomnia—Temozolomide—malignant glioma	0.000772	0.00125	CcSEcCtD
Pregabalin—Decreased appetite—Carmustine—malignant glioma	0.000768	0.00124	CcSEcCtD
Pregabalin—Paraesthesia—Temozolomide—malignant glioma	0.000766	0.00124	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Carmustine—malignant glioma	0.000762	0.00123	CcSEcCtD
Pregabalin—Dyspnoea—Temozolomide—malignant glioma	0.000761	0.00123	CcSEcCtD
Pregabalin—Somnolence—Temozolomide—malignant glioma	0.000759	0.00123	CcSEcCtD
Pregabalin—Pain—Carmustine—malignant glioma	0.000755	0.00122	CcSEcCtD
Pregabalin—Constipation—Carmustine—malignant glioma	0.000755	0.00122	CcSEcCtD
Pregabalin—Decreased appetite—Temozolomide—malignant glioma	0.000742	0.0012	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000737	0.00119	CcSEcCtD
Pregabalin—Fatigue—Temozolomide—malignant glioma	0.000736	0.00119	CcSEcCtD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000732	0.0191	CbGpPWpGaD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—YWHAE—malignant glioma	0.000731	0.0191	CbGpPWpGaD
Pregabalin—Pain—Temozolomide—malignant glioma	0.00073	0.00118	CcSEcCtD
Pregabalin—Constipation—Temozolomide—malignant glioma	0.00073	0.00118	CcSEcCtD
Pregabalin—Feeling abnormal—Carmustine—malignant glioma	0.000728	0.00118	CcSEcCtD
Pregabalin—Gastrointestinal pain—Carmustine—malignant glioma	0.000722	0.00117	CcSEcCtD
Pregabalin—Feeling abnormal—Temozolomide—malignant glioma	0.000703	0.00114	CcSEcCtD
Pregabalin—Abdominal pain—Carmustine—malignant glioma	0.000698	0.00113	CcSEcCtD
Pregabalin—Body temperature increased—Carmustine—malignant glioma	0.000698	0.00113	CcSEcCtD
Pregabalin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000698	0.00113	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000693	0.0181	CbGpPWpGaD
Pregabalin—Urticaria—Temozolomide—malignant glioma	0.000678	0.0011	CcSEcCtD
Pregabalin—Abdominal pain—Temozolomide—malignant glioma	0.000675	0.00109	CcSEcCtD
Pregabalin—Body temperature increased—Temozolomide—malignant glioma	0.000675	0.00109	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000674	0.0176	CbGpPWpGaD
Pregabalin—Hypersensitivity—Carmustine—malignant glioma	0.000651	0.00105	CcSEcCtD
Pregabalin—Asthenia—Carmustine—malignant glioma	0.000634	0.00102	CcSEcCtD
Pregabalin—Hypersensitivity—Temozolomide—malignant glioma	0.000629	0.00102	CcSEcCtD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000624	0.0163	CbGpPWpGaD
Pregabalin—Asthenia—Temozolomide—malignant glioma	0.000612	0.00099	CcSEcCtD
Pregabalin—Diarrhoea—Carmustine—malignant glioma	0.000604	0.000977	CcSEcCtD
Pregabalin—Pruritus—Temozolomide—malignant glioma	0.000604	0.000977	CcSEcCtD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—GJA1—malignant glioma	0.000601	0.0157	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—BCHE—malignant glioma	0.000597	0.0156	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000594	0.0155	CbGpPWpGaD
Pregabalin—Dizziness—Carmustine—malignant glioma	0.000584	0.000945	CcSEcCtD
Pregabalin—Diarrhoea—Temozolomide—malignant glioma	0.000584	0.000945	CcSEcCtD
Pregabalin—Dizziness—Temozolomide—malignant glioma	0.000564	0.000913	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000563	0.0147	CbGpPWpGaD
Pregabalin—Vomiting—Carmustine—malignant glioma	0.000562	0.000908	CcSEcCtD
Pregabalin—SLC1A1—Neuronal System—SLC6A3—malignant glioma	0.000561	0.0146	CbGpPWpGaD
Pregabalin—Rash—Carmustine—malignant glioma	0.000557	0.000901	CcSEcCtD
Pregabalin—Dermatitis—Carmustine—malignant glioma	0.000556	0.0009	CcSEcCtD
Pregabalin—Headache—Carmustine—malignant glioma	0.000553	0.000895	CcSEcCtD
Pregabalin—Vomiting—Temozolomide—malignant glioma	0.000543	0.000878	CcSEcCtD
Pregabalin—Rash—Temozolomide—malignant glioma	0.000538	0.00087	CcSEcCtD
Pregabalin—Dermatitis—Temozolomide—malignant glioma	0.000538	0.00087	CcSEcCtD
Pregabalin—Headache—Temozolomide—malignant glioma	0.000535	0.000865	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000529	0.0138	CbGpPWpGaD
Pregabalin—Nausea—Carmustine—malignant glioma	0.000525	0.000849	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—RTEL1—malignant glioma	0.000511	0.0133	CbGpPWpGaD
Pregabalin—Nausea—Temozolomide—malignant glioma	0.000507	0.00082	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000472	0.0123	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000444	0.0116	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—BCHE—malignant glioma	0.000431	0.0113	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—RTEL1—malignant glioma	0.000428	0.0112	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—SLC6A3—malignant glioma	0.000406	0.0106	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000397	0.0104	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—BCHE—malignant glioma	0.000362	0.00943	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000345	0.009	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—SLC6A3—malignant glioma	0.00034	0.00887	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000333	0.00869	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000332	0.00866	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000317	0.00827	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—BRAF—malignant glioma	0.000304	0.00794	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000302	0.00787	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—COX8A—malignant glioma	0.000294	0.00766	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000287	0.00749	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—MDM2—malignant glioma	0.000255	0.00665	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—RAF1—malignant glioma	0.000254	0.00663	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ASMT—malignant glioma	0.00025	0.00651	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—COX8A—malignant glioma	0.000246	0.00642	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000241	0.00628	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000241	0.00628	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—RAF1—malignant glioma	0.00024	0.00626	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—BCAN—malignant glioma	0.000235	0.00612	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—BRAF—malignant glioma	0.00022	0.00574	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ASMT—malignant glioma	0.000209	0.00546	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000202	0.00526	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000201	0.00524	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—BCAN—malignant glioma	0.000197	0.00513	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—IDH2—malignant glioma	0.000189	0.00493	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—BRAF—malignant glioma	0.000184	0.00481	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—MDM2—malignant glioma	0.000184	0.00481	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—RAF1—malignant glioma	0.000184	0.00479	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP2B6—malignant glioma	0.000178	0.00464	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—IDH1—malignant glioma	0.000163	0.00424	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—IDH2—malignant glioma	0.000158	0.00413	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SPHK1—malignant glioma	0.000157	0.0041	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—MDM2—malignant glioma	0.000155	0.00403	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP2C18—malignant glioma	0.000154	0.00402	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—RAF1—malignant glioma	0.000154	0.00402	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP2B6—malignant glioma	0.000149	0.00389	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000137	0.00357	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—IDH1—malignant glioma	0.000136	0.00356	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SPHK1—malignant glioma	0.000132	0.00344	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP2C18—malignant glioma	0.000129	0.00337	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTT1—malignant glioma	0.000125	0.00325	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PTGS1—malignant glioma	0.000117	0.00305	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—BCHE—malignant glioma	0.000109	0.00283	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SLC5A5—malignant glioma	0.000107	0.0028	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTT1—malignant glioma	0.000104	0.00273	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PTGS1—malignant glioma	9.79e-05	0.00255	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—BCHE—malignant glioma	9.1e-05	0.00237	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SLC5A5—malignant glioma	8.99e-05	0.00235	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTP1—malignant glioma	8.64e-05	0.00225	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CAT—malignant glioma	8.41e-05	0.00219	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NCOR1—malignant glioma	7.94e-05	0.00207	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTP1—malignant glioma	7.24e-05	0.00189	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CAT—malignant glioma	7.05e-05	0.00184	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NCOR1—malignant glioma	6.66e-05	0.00174	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CAV1—malignant glioma	6.47e-05	0.00169	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CG—malignant glioma	5.9e-05	0.00154	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PPARG—malignant glioma	5.69e-05	0.00148	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CAV1—malignant glioma	5.43e-05	0.00142	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CD—malignant glioma	5.18e-05	0.00135	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CG—malignant glioma	4.94e-05	0.00129	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PPARG—malignant glioma	4.77e-05	0.00124	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CB—malignant glioma	4.52e-05	0.00118	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PTGS2—malignant glioma	4.48e-05	0.00117	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CD—malignant glioma	4.34e-05	0.00113	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PTEN—malignant glioma	3.91e-05	0.00102	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CB—malignant glioma	3.79e-05	0.000988	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PTGS2—malignant glioma	3.75e-05	0.000979	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PTEN—malignant glioma	3.27e-05	0.000854	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CA—malignant glioma	2.75e-05	0.000719	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CA—malignant glioma	2.31e-05	0.000602	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—AKT1—malignant glioma	2.25e-05	0.000587	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—AKT1—malignant glioma	1.89e-05	0.000492	CbGpPWpGaD
